EMAIL THIS PAGE TO A FRIEND

BMC physiology

Identification of novel Kirrel3 gene splice variants in adult human skeletal muscle.


PMID 25488023

Abstract

Multiple cell types including trophoblasts, osteoclasts and myoblasts require somatic cell fusion events as part of their physiological functions. In Drosophila Melanogaster the paralogus type 1 transmembrane receptors and members of the immunoglobulin superfamily Kin of Irre (Kirre) and roughest (Rst) regulate myoblast fusion during embryonic development. Present within the human genome are three homologs to Kirre termed Kin of Irre like (Kirrel) 1, 2 and 3. Currently it is unknown if Kirrel3 is expressed in adult human skeletal muscle. We investigated (using PCR and Western blot) Kirrel3 in adult human skeletal muscle samples taken at rest and after mild exercise induced muscle damage. Kirrel3 mRNA expression was verified by sequencing and protein presence via blotting with 2 different anti-Kirrel3 protein antibodies. Evidence for three alternatively spliced Kirrel3 mRNA transcripts in adult human skeletal muscle was obtained. Kirrel3 mRNA in adult human skeletal muscle was detected at low or moderate levels, or not at all. This sporadic expression suggests that Kirrel3 is expressed in a pulsatile manner. Several anti Kirrel3 immunoreactive proteins were detected in all adult human skeletal muscle samples analysed and results suggest the presence of different isoforms or posttranslational modification, or both. The results presented here demonstrate for the first time that there are at least 3 splice variants of Kirrel3 expressed in adult human skeletal muscle, two of which have never previously been identified in human muscle. Importantly, mRNA of all splice variants was not always present, a finding with potential physiological relevance. These initial discoveries highlight the need for more molecular and functional studies to understand the role of Kirrel3 in human skeletal muscle.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

B0126
Bromophenol Blue
C19H10Br4O5S
114391
Bromophenol Blue, ACS reagent
C19H10Br4O5S
03609
Ethylenediaminetetraacetic acid, BioUltra, ≥99.0% (KT)
C10H16N2O8
03620
Ethylenediaminetetraacetic acid, ≥98.0% (KT)
C10H16N2O8
03690
Ethylenediaminetetraacetic acid solution, BioUltra, for molecular biology, pH 8.0, ~0.5 M in H2O
C10H16N2O8
1295607
Glycerin, United States Pharmacopeia (USP) Reference Standard
C3H8O3
PHR1020
Glycerin, Pharmaceutical Secondary Standard; Certified Reference Material
C3H8O3
49779
Glycerol, tested according to Ph.Eur., anhydrous
C3H8O3
77067
Glycerol, analytical standard
C3H8O3
12146
Glycerol 3 M solution, 3 M
C3H8O3 · xH2O
T1378
Sigma 7-9®, ≥99% (titration), crystalline
C4H11NO3
71726
Sodium dodecyl sulfate, for ion pair chromatography, ≥99.0%
C12H25NaO4S
Y0000620
Sodium laurilsulfate, European Pharmacopoeia (EP) Reference Standard
C12H25NaO4S
154563
Tris(hydroxymethyl)aminomethane, ultrapure grade, ≥99.9%
C4H11NO3
252859
Tris(hydroxymethyl)aminomethane, ACS reagent, ≥99.8%
C4H11NO3
RDD008
Trizma® base, anhydrous, free-flowing, Redi-Dri, ≥99.9%
C4H11NO3
T1503
Trizma® base, Primary Standard and Buffer, ≥99.9% (titration), crystalline
C4H11NO3
T6066
Trizma® base, BioPerformance Certified, meets EP, USP testing specifications, cell culture tested, ≥99.9% (titration)
C4H11NO3
T6791
Trizma® base, BioXtra, pH 10.5-12.0 (1 M in H2O), ≥99.9% (titration)
C4H11NO3
T4661
Trizma® base, ≥99.9% (titration), crystalline
C4H11NO3
93362
Trizma® base, BioUltra, for molecular biology, ≥99.8% (T)
C4H11NO3
93352
Trizma® base, ≥99.0% (T)
C4H11NO3
93350
Trizma® base, puriss. p.a., ≥99.7% (T)
C4H11NO3
33742
Trizma® base, puriss. p.a., buffer substance, ≥99.5%
C4H11NO3
04577
Trizma® base, tested according to Ph.Eur.
C4H11NO3
93440
Trizma® base, certified reference material for titrimetry, certified by BAM, according to ISO 17025, ≥99.5%
C4H11NO3
T2550000
Trometamol, European Pharmacopoeia (EP) Reference Standard
C4H11NO3
T6687
Tromethamine, meets USP testing specifications
C4H11NO3
RES3137T-A7
Tromethamine, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production., suitable for cell culture, meets USP testing specifications
C4H11NO3
RES3193T-A7
Tromethamine, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production, suitable for cell culture, Meets USP, EP, JPC, BP testing specifications.
C4H11NO3